SCHEMBL3263219

SCHEMBL3263219

Nc1nc(-n2cc(C(=O)O)c(=O)c3nc(F)c(F)c(Cl)c32)c(F)cc1F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.57
CYP2C9 P11712 2/20 0.57
ALDH1A1 P00352 4/20 0.35
HTT P42858 2/20 0.35
STAT3 P40763 1/20 0.34
TOP1 P11387 2/20 0.34
EPHA2 P29317 1/20 0.33
FLT4 P35916 1/20 0.33
GSK3B P49841 1/20 0.33
RARB P10826 1/20 0.33
TBXAS1 P24557 1/20 0.33
SLC6A3 Q01959 1/20 0.33
PIM1 P11309 1/20 0.33
KMT2A Q03164 1/20 0.33
DPP4 P27487 2/20 0.32
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32
TOP2A P11388 1/20 0.31
TOP2B Q02880 1/20 0.31
POLB P06746 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2670076 0.84 CYP2C9 (0.71) CYP3A4CYP2C9ALDH1A1HTTTOP1
SCHEMBL7004180 0.83 CYP3A4 (0.57) CYP3A4CYP2C9ALDH1A1HTTSTAT3
SCHEMBL7861232 0.79 STAT3 (0.59) CYP3A4CYP2C9ALDH1A1HTTSTAT3
SCHEMBL7012892 0.78 CYP3A4 (0.52) CYP3A4CYP2C9ALDH1A1HTTSTAT3
SCHEMBL4747757 0.78 CYP2C9 (0.69) CYP3A4CYP2C9ALDH1A1HTTTOP1
SCHEMBL7006625 0.78 CYP2C9 (0.63) CYP3A4CYP2C9ALDH1A1HTTSTAT3
SCHEMBL2920517 0.77 CYP2C9 (0.63) CYP3A4CYP2C9ALDH1A1HTTTOP1
SCHEMBL7858473 0.77 CYP3A4 (0.52) CYP3A4CYP2C9ALDH1A1HTTSTAT3
SCHEMBL2921601 0.77 CYP2C9 (0.62) CYP3A4CYP2C9ALDH1A1HTTTOP1
SCHEMBL2923696 0.77 CYP3A4 (0.62) CYP3A4CYP2C9ALDH1A1TOP1EPHA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010056633-A2 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES JANSSEN PHARMACEUTICA NV (BE) 2010-05-20 WO disclosed
US-20090156577-A1 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES JANSSEN PHARMACEUTICA NV (BE) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156577-A1 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES NQO2, QRFPR, NQO1 CYP3A4 108/4885CYP2C9 174/4885ALDH1A1 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.